Haier Biomedical was founded to focus on design, manufacturing, marketing and sales of laboratory equipment. Using the concept of IoT, Haier Biomedical has become a provider of comprehensive solutions for various biotechnological challenges.
Haier Biomedical, the world’s only complete cold chain provider (-196°C to +8°C), has storage solutions for biological sample banks, blood safety, vaccine safety, medical supplies and reagent safety. It also has a range of complementary products such as CO2 incubators and clean air cabinets including Class 2 microbiological safety cabinets.
Connecting laboratory equipment and operations with IoT-based technology makes it possible for real-time monitoring and tracking of facilities. These innovations help science-focused operations reduce resources and support best practices in sustainability.
As of now, Haier Biomedical and its subsidiaries have achieved a total of 263 approved and pending patents, including 65 invention patents. In China, our core R & D team have led or engaged in the drafting of 9 national and industry standards for the biomedical cryogenic storage industry, basically covering all biomedical cryogenic storage products. Furthermore, Haier participated in the drafting of World Health Organization (WHO) international standards, showing true leadership and development for the industry.
In the UK, Haier Biomedical’s subsidiary was established in 2016, when Haier bought the cold storage division of its UK distributor. With offices and warehousing within the UK it supports customers with a local sales network, as well as, after sales with in-house technical support, trained field service engineers and stock of spare parts.
